In this eBook, Malvern Panalytical will guide you through the different challenges, technologies and solutions facing LNP vector analysis. This information can help empower everything from vector design through formulation development and manufacturing, enabling more confident decision-making for faster delivery of better medicines to patients in need.
Lipid-based nanoparticles (LNPs) hold great promise for the treatment, cure, and prevention of a range of challenging medical conditions — from genetic diseases to cancers. Not only do these vectors enable the efficient delivery of therapeutic payloads such as RNA, but (unlike viral vectors), they can also be manufactured using cell-free production processes with the potential for rapid scaling. However, LNP therapies are analytically challenging to develop and manufacture.
As such, developers urgently need a suite of fit-for purpose orthogonal analytical techniques that are complementary to traditional approaches. Such tools can help guide and optimize everything from vector design through formulation development and manufacturing.
In this eBook, Malvern Panalytical will guide you through the different challenges, technologies and solutions facing LNP vector analysis. This information can help empower everything from vector design through formulation development and manufacturing, enabling more confident decision-making for faster delivery of better medicines to patients in need.
